Drug Search Results
More Filters [+]

HTC-867

Alternative Names: htc-867, htc867, htc 867
Latest Update: 2010-12-29
Latest Update Note: Clinical Trial Update

Product Description

For Schizophrenia

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for HTC-867

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Schizophrenia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

3253A1-1001-JA

P1

Completed

Schizophrenia

2009-04-01

3253A1-1000

P1

Terminated

Schizophrenia

2009-04-01

Recent News Events

Date

Type

Title